Trial Profile
Multi-center, Randomized, Double-blind, Active Comparator- Controlled, Parallel Study Evaluating the Efficacy and Safety of HE10 in Subjects With Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Huons
- 16 Jul 2015 New trial record